Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

fibrinogen

fibrinogen
  • Restricted RiaSTAP --> Restricted to Outpatient Medical ~OR~ use in pediatric patients for treatment of acute bleeding episodes due to congenital fibrinogen deficiency or fibrinogen depletion due to cancer, hepatic disease, chemotherapy, or hemorrhage.
  • Restricted Miscellaneous Programs
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Fibryga POWDER FOR INJECTION, INTRAVENOUS      
RiaSTAP POWDER FOR INJECTION, INTRAVENOUS      
Comments:

 

RiaSTAP/Fibryga is restricted to use in pediatric patients for treatment of acute bleeding episodes due to congenital fibrinogen deficiency or fibrinogen depletion due to cancer, hepatic disease, chemotherapy, or hemorrhage or other FDA approved indications.

Use most cost-effective product.

 

Reviewed: November 16, 2010

Last updated: May. 11, 2020
  • Formulary, Not Routinely Stocked: Fibryga






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved